334 related articles for article (PubMed ID: 16712492)
21. Compounds that bind APP and inhibit Abeta processing in vitro suggest a novel approach to Alzheimer disease therapeutics.
Espeseth AS; Xu M; Huang Q; Coburn CA; Jones KL; Ferrer M; Zuck PD; Strulovici B; Price EA; Wu G; Wolfe AL; Lineberger JE; Sardana M; Tugusheva K; Pietrak BL; Crouthamel MC; Lai MT; Dodson EC; Bazzo R; Shi XP; Simon AJ; Li Y; Hazuda DJ
J Biol Chem; 2005 May; 280(18):17792-7. PubMed ID: 15737955
[TBL] [Abstract][Full Text] [Related]
22. Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme.
Spoelgen R; von Arnim CA; Thomas AV; Peltan ID; Koker M; Deng A; Irizarry MC; Andersen OM; Willnow TE; Hyman BT
J Neurosci; 2006 Jan; 26(2):418-28. PubMed ID: 16407538
[TBL] [Abstract][Full Text] [Related]
23. Toward the characterization and identification of gamma-secretases using transition-state analogue inhibitors.
Moore CL; Diehl TS; Selkoe DJ; Wolfe MS
Ann N Y Acad Sci; 2000; 920():197-205. PubMed ID: 11193150
[TBL] [Abstract][Full Text] [Related]
24. Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides.
Evin G; Weidemann A
Peptides; 2002 Jul; 23(7):1285-97. PubMed ID: 12128085
[TBL] [Abstract][Full Text] [Related]
25. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
26. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
[TBL] [Abstract][Full Text] [Related]
27. The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo.
Crameri A; Biondi E; Kuehnle K; Lütjohann D; Thelen KM; Perga S; Dotti CG; Nitsch RM; Ledesma MD; Mohajeri MH
EMBO J; 2006 Jan; 25(2):432-43. PubMed ID: 16407971
[TBL] [Abstract][Full Text] [Related]
28. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase.
Sauder JM; Arthur JW; Dunbrack RL
J Mol Biol; 2000 Jul; 300(2):241-8. PubMed ID: 10873463
[TBL] [Abstract][Full Text] [Related]
29. Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP).
Marlow L; Cain M; Pappolla MA; Sambamurti K
J Mol Neurosci; 2003; 20(3):233-9. PubMed ID: 14501002
[TBL] [Abstract][Full Text] [Related]
30. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein.
Cordy JM; Hussain I; Dingwall C; Hooper NM; Turner AJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11735-40. PubMed ID: 14504402
[TBL] [Abstract][Full Text] [Related]
31. Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy?
Nawrot B
Acta Biochim Pol; 2004; 51(2):431-44. PubMed ID: 15218540
[TBL] [Abstract][Full Text] [Related]
32. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
Sun X; Wang Y; Qing H; Christensen MA; Liu Y; Zhou W; Tong Y; Xiao C; Huang Y; Zhang S; Liu X; Song W
FASEB J; 2005 May; 19(7):739-49. PubMed ID: 15857888
[TBL] [Abstract][Full Text] [Related]
33. The physical approximation of APP and BACE-1: A key event in alzheimer's disease pathogenesis.
Sun J; Roy S
Dev Neurobiol; 2018 Mar; 78(3):340-347. PubMed ID: 29106038
[TBL] [Abstract][Full Text] [Related]
34. Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1.
Li Q; Südhof TC
J Biol Chem; 2004 Mar; 279(11):10542-50. PubMed ID: 14699153
[TBL] [Abstract][Full Text] [Related]
35. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.
Farzan M; Schnitzler CE; Vasilieva N; Leung D; Choe H
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9712-7. PubMed ID: 10931940
[TBL] [Abstract][Full Text] [Related]
36. BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells.
Jämsä A; Belda O; Edlund M; Lindström E
J Biomed Sci; 2011 Oct; 18(1):76. PubMed ID: 22018341
[TBL] [Abstract][Full Text] [Related]
37. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
[TBL] [Abstract][Full Text] [Related]
38. X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein.
King GD; Cherian K; Turner RS
J Neurochem; 2004 Feb; 88(4):971-82. PubMed ID: 14756819
[TBL] [Abstract][Full Text] [Related]
39. Regulation of APP cleavage by alpha-, beta- and gamma-secretases.
Nunan J; Small DH
FEBS Lett; 2000 Oct; 483(1):6-10. PubMed ID: 11033346
[TBL] [Abstract][Full Text] [Related]
40. Progress in the development of nonpeptidomimetic BACE 1 inhibitors for Alzheimer's disease.
Huang WH; Sheng R; Hu YZ
Curr Med Chem; 2009; 16(14):1806-20. PubMed ID: 19442147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
